Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 3/2004

01-04-2004

Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer

Authors: Elizabeth A. Platz, Michael F. Leitzmann, Bruce W. Hollis, Walter C. Willett, Edward Giovannucci

Published in: Cancer Causes & Control | Issue 3/2004

Login to get access
Metadata
Title
Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer
Authors
Elizabeth A. Platz
Michael F. Leitzmann
Bruce W. Hollis
Walter C. Willett
Edward Giovannucci
Publication date
01-04-2004
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 3/2004
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/B:CACO.0000024245.24880.8a

Other articles of this Issue 3/2004

Cancer Causes & Control 3/2004 Go to the issue

OriginalPaper

GSTM1 Null Genotype, Red Meat Consumption and Breast Cancer Risk (The Netherlands)

OriginalPaper

Maternal Risk Factors for Testicular Cancer: A Population-Based Case–Control Study (UK)

OriginalPaper

Bias in Completeness of Birthplace Data for Asian Groups in a Population-Based Cancer Registry (United States)

OriginalPaper

Occupational Risk Factors for Lung Cancer in Men and Women: A Population-Based Case–Control Study in Italy

OriginalPaper

International Trends in Prostate-Cancer Mortality: The Decrease is Continuing and Spreading

OriginalPaper

Correlation of Blood Sex Steroid Hormones with Body Size, Body Fat Distribution, and Other Known Risk Factors for Breast Cancer in Post-Menopausal Chinese Women
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits